Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glass Particle Contamination and PDPH in C-Section
NCT06683807Not yet recruiting
- Sponsor
- Assiut University
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of bupivacaine in cesarean section (2 arms), sponsored by Assiut University. Primary endpoint: Incidence of post-dural puncture headache at 120 hours. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
cesarean section
Beyond the preview
Go deeper on NCT06683807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06683807.